News
ATAI
4.370
-0.68%
-0.030
Weekly Report: what happened at ATAI last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at ATAI last week (1117-1121)?
Weekly Report · 11/24 10:27
AtaiBeckley: Strong Buy Rating Backed by Promising Clinical Data and Robust Financial Position
TipRanks · 11/19 19:35
Weekly Report: what happened at ATAI last week (1110-1114)?
Weekly Report · 11/17 10:27
Psychedelic: Atai Beckley, Cybin report quarterly earnings
TipRanks · 11/13 16:31
ATAI Life Sciences’ BPL-003 Gains Momentum with Breakthrough Therapy Designation and Strategic Merger, Reinforcing Buy Rating
TipRanks · 11/13 16:15
ATAI Life Sciences: Promising Clinical Developments and Strong Financial Position Drive Buy Rating
TipRanks · 11/13 14:06
AtaiBeckley Advances Mental Health Therapies with FDA Milestone
TipRanks · 11/13 04:34
ATAI Life Sciences GAAP EPS of -$0.28 misses by $0.17, revenue of $0.75M beats by $0.69M
Seeking Alpha · 11/12 12:31
Canaccord Genuity Reaffirms Their Buy Rating on ATAI Life Sciences (ATAI)
TipRanks · 11/11 12:26
ATAI Life Sciences’ BPL-003 Shows Promising Phase 2b Results, Earning Buy Rating
TipRanks · 11/10 18:05
GH Research price target lowered to $35 from $40 at H.C. Wainwright
TipRanks · 11/10 16:10
Buy Rating Affirmed on Promising Clinical Data and Strategic Developments for AtaiBeckley
TipRanks · 11/10 15:15
Atai Beckley announces data from Phase 2b OLE study of BPL-003
TipRanks · 11/10 12:51
Weekly Report: what happened at ATAI last week (1103-1107)?
Weekly Report · 11/10 10:24
Psychedelic: Compass Pathways, GH Research report Q3 earnings
TipRanks · 11/06 16:35
ATAI Life Sciences (ATAI) Receives a Buy from Oppenheimer
TipRanks · 11/06 14:30
ATAI Life Sciences Files Prospectus for Share Resale
TipRanks · 11/05 13:58
ATAI Life Sciences Completes Acquisition of Beckley Psytech
TipRanks · 11/05 13:20
Atai Life Sciences completes combination between atai Life, Beckley Psytech
TipRanks · 11/05 12:46
More
Webull provides a variety of real-time ATAI stock news. You can receive the latest news about Atai Beckley Inc through multiple platforms. This information may help you make smarter investment decisions.
About ATAI
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.